Inderpal Randhawa

Inderpal Randhawa

M.D.

Titles

  • Founder – Chief Executive Officer, Food Allergy Institute
  • Founder – Chief Executive Officer, The Translational Pulmonary and Immunology Research Center
  • Medical Director, Pediatric Pulmonary Institute Miller Children’s Hospital
  • Medical Director, Clinical Immunology & Allergy, Miller Children’s Hospital
  • Program Director, Pediatric Pulmonology Fellowship – UCI- MCH
  • Founder, CEO, B.A.R.I.C. Data Loop
Download

Dr. Randhawa CV: visualcv.com/docrandhawa

(562) 490-9900

docrandhawa@tpirc.org

www.tpirc.org

CLINICAL

  • Orphan Lung and Immune Diseases
  • Food Anaphylaxis – Pediatric
  • Food Anaphylaxis – Adult
  • Immune Deficiency

Board Certifcations

  • American Board of Allergy & Immunology, Board Certification, October 2007 (Active)
  • American Board of Pediatrics, Pediatric Pulmonology, Board Certification, November 2010 (Active)
  • American Board of Internal Medicine, Pulmonary Medicine, Specialty Pathway, 1/2015 (Active)
  • American Board of Internal Medicine, Board Certification, August 2005 (Active)
  • American Board of Pediatrics, Board Certification, October 2005 (Active

RESEARCH

  • Allergy & Immunology/Pediatric Pulmonology/Transitional Pulmonary Medicine
  • Adult Cystic Fibrosis
  • Transitional Health Care design (pediatric to adult medicine)
  • Lung Transplantation
  • Immunomodulatory Therapeutics
  • Food Allergy Diagnostics and Therapeutics
  • Primary Ciliary Dyskinesia molecular and cellular models
  • Sickle Cell Pulmonary disorders
  • Immune deficiency – primary, secondary and comorbid
  • Bronchopulmonary Dysplasia – translational, cellular and clinical research

DATA SCIENCE

  • BARIC DataLoop, Inc. 
  • TIP Program, The machine learning architecture for the Food Allergy Institute
  • Agricultural Science
  • Biosimilar Protein Immunotherapy

CURRENT RESEARCH

  • Identifying the Genetic variants that influence susceptibility to and the natural history of eosinophilic esophagitis in a Southern California population. UCLA and Cedars Sinai Hospital.  
  • Characterization of anaerobic and aerobic bacteria in bronchiectasis and cystic fibrosis via microarray analysis specific to treatment modification. 
  • Perinatal cytokine production and characterization in lung disease of prematurity and associated risk of intermittent wheezing episodes. To determine the cytokine profile in a cohort of neonates compared with controls (non – bronchopulmonary dysplasia) and clinically assess the development of intermittent wheezing episodes and change in pulmonary function. 
  • Novel murine bronchopulmonary dysplasia model utilizing non invasive CPAP. Validation model through immune histochemistry and M1-M2 characterization. 
  • Neutrophil targeted cellular culture model development to study mucoviscidosis disorders of the lung. 
  • Remission biomarker trajectory in the Tolerance Induction Program. 
  • Role of Dysanapsis in lung disease metabolics.
  • Single cell cellular expression in the Tolerance Induction Program.
  • Long term remission lymphocyte profiles in the Tolerance Induction Program.
  • Primary Ciliary Dyskinesia organoid model.

SCIENTIFIC ADVISORY BOARDS

  • The Translation Pulmonary and Immunology Research Center:  6/14 – present
  • Global Genes Scientific Advisory Board: 9/14 – 9/19
  • The Coalition Against Pediatric Pain: 4/13 – 8/16

PROFESSIONAL SOCIETIES​

  • International Society for Heart and Lung Transplant, Member, 7/10- present
  • American Thoracic Society, Member, 7/10 – present
  • American College Asthma, Allergy & Immunology, Member, 7/05- present
  • American Academy Asthma, Allergy & Immunology, Member, 7/05- present
  • American College of Physicians, Member, 8/05- present
  • American Academy of Pediatrics, Fellow, 8/05- present

PROFESSIONAL COMMITTEES

  • JCAHO Asthma Center of Excellence Steering Committee, Physician Chair: 2019 – present
  • Graduate Medical Education Committee, Director: 2011 – present
  • Pediatric Careline Committee, Member: 2018 – present

FORWARD INNOVATION TECHNOLOGY (501c8)

  • 2023 to present
  • Innovative technology lodge targeting agricultural sustainability and data science 

ACTIVE APPOINMENTS

  • The Translational Pulmonary & Immunology Research Center, Founder, CEO, Chief Medical & Scientific Officer
  • The Southern California Food Allergy Institute, Founder, Chief Medical & Scientific Officer
  • Medical Director of Pediatric Pulmonology, Clinical Immunology & Allergy at Miller Children’s Hospital
  • Miller Children’s Hospital, Pediatric Pulmonary Fellowship, Program Director
  • Lung and Allergy Health Associates, Chief Physician
  • Harbor UCLA, Pediatric Division of Allergy & Immunology, Clinic Attending
  • UCLA, Wadsworth Campus, Department of Medicine, Allergy & Immunology, Clinic Attending  and Immunology/Allergy Fellowship Research Coordinator
  • Torrance Memorial Medical Center, Physician Attending
  • Long Beach Memorial Medical Center, Physician Attending
  • University of Southern California, Keck School of Medicine, Department of Pediatrics, Affiliate Research Scientist 
  • Cystic Fibrosis Center Director, Miller Children’s Hospital
  • Newborn Screening Center Director, Pulmonary Disease, Miller Children’s Hospital

FACULTY APPOINMENT​

  • Clinical Professor of Pediatrics, UC Irvine School of Medicine
  • Assistant Clinical Professor of Medicine, UCLA David Geffen School of Medicine, 2007 to 2019

Share this:

Like this:

Like Loading...